A three gene signature predicts response to selinexor in multiple myeloma
View ORCID ProfilePaula Restrepo, View ORCID ProfileSherry Bhalla, View ORCID ProfileAdolfo Aleman, View ORCID ProfileVioletta Leshchenko, View ORCID ProfileDavid T Melnekoff, Sarita Agte, Joy Jiang, View ORCID ProfileDeepu Madduri, View ORCID ProfileJoshua Richter, View ORCID ProfileShambavi Richard, View ORCID ProfileAjai Chari, View ORCID ProfileHearn Jay Cho, View ORCID ProfileSundar Jagannath, Christopher J Walker, View ORCID ProfileYosef Landesman, View ORCID ProfileAlessandro Laganà, View ORCID ProfileSamir Parekh
doi: https://doi.org/10.1101/2022.02.25.22271401
Paula Restrepo
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
2Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Sherry Bhalla
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
2Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Adolfo Aleman
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
5Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Violetta Leshchenko
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
3Department of Hematology & Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
David T Melnekoff
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
4Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States
5Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Sarita Agte
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Joy Jiang
5Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Deepu Madduri
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
6Janssen Pharmaceutical Research & Development, Raritan, NJ, United States
Joshua Richter
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Shambavi Richard
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Ajai Chari
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Hearn Jay Cho
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
7Multiple Myeloma Research Foundation, Norwalk, CT, United States
Sundar Jagannath
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Christopher J Walker
8Karyopharm Therapeutics, Newton, MA, United States
Yosef Landesman
8Karyopharm Therapeutics, Newton, MA, United States
Alessandro Laganà
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
2Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States
4Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Samir Parekh
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Posted March 08, 2022.
A three gene signature predicts response to selinexor in multiple myeloma
Paula Restrepo, Sherry Bhalla, Adolfo Aleman, Violetta Leshchenko, David T Melnekoff, Sarita Agte, Joy Jiang, Deepu Madduri, Joshua Richter, Shambavi Richard, Ajai Chari, Hearn Jay Cho, Sundar Jagannath, Christopher J Walker, Yosef Landesman, Alessandro Laganà, Samir Parekh
medRxiv 2022.02.25.22271401; doi: https://doi.org/10.1101/2022.02.25.22271401
A three gene signature predicts response to selinexor in multiple myeloma
Paula Restrepo, Sherry Bhalla, Adolfo Aleman, Violetta Leshchenko, David T Melnekoff, Sarita Agte, Joy Jiang, Deepu Madduri, Joshua Richter, Shambavi Richard, Ajai Chari, Hearn Jay Cho, Sundar Jagannath, Christopher J Walker, Yosef Landesman, Alessandro Laganà, Samir Parekh
medRxiv 2022.02.25.22271401; doi: https://doi.org/10.1101/2022.02.25.22271401
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11633)
- Forensic Medicine (10)
- Gastroenterology (685)
- Genetic and Genomic Medicine (3638)
- Geriatric Medicine (342)
- Health Economics (624)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3393)
- Nursing (193)
- Nutrition (512)
- Oncology (1783)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6031)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)